BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24468311)

  • 1. Pathology of peripheral T-cell lymphomas: where do we stand?
    Gaulard P; de Leval L
    Semin Hematol; 2014 Jan; 51(1):5-16. PubMed ID: 24468311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology and biology of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Histopathology; 2011 Jan; 58(1):49-68. PubMed ID: 21261683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral T cell lymphoma in Asia.
    Park S; Ko YH
    Int J Hematol; 2014 Mar; 99(3):227-39. PubMed ID: 24481942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New biomarkers in T-cell lymphomas.
    Bisig B; Gaulard P; de Leval L
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):13-28. PubMed ID: 22409820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
    Feldman AL; Laurent C; Narbaitz M; Nakamura S; Chan WC; de Leval L; Gaulard P
    Virchows Arch; 2023 Jan; 482(1):265-279. PubMed ID: 36210383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral T-cell lymphomas.
    Macon WR
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):829-42. PubMed ID: 19577171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
    Iqbal J; Weisenburger DD; Chowdhury A; Tsai MY; Srivastava G; Greiner TC; Kucuk C; Deffenbacher K; Vose J; Smith L; Au WY; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Ko YH; Sng I; Liu X; Loughran TP; Armitage J; Chan WC;
    Leukemia; 2011 Feb; 25(2):348-58. PubMed ID: 21052088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls.
    Jaffe ES; Nicolae A; Pittaluga S
    Mod Pathol; 2013 Jan; 26 Suppl 1(Suppl 1):S71-87. PubMed ID: 23281437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microenvironment in T-cell lymphomas: emerging themes.
    Gaulard P; de Leval L
    Semin Cancer Biol; 2014 Feb; 24():49-60. PubMed ID: 24316493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to nodal-based T-cell lymphomas.
    de Leval L
    Pathology; 2020 Jan; 52(1):78-99. PubMed ID: 31785821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
    Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
    Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
    McKelvie PA; Thompson PA; Tam CS
    Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions.
    Bisig B; Savage KJ; De Leval L
    Haematologica; 2023 Dec; 108(12):3227-3243. PubMed ID: 38037800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral T-cell lymphoma classification: the matter of cellular derivation.
    Piccaluga PP; Agostinelli C; Tripodo C; Gazzola A; Bacci F; Sabattini E; Pileri SA;
    Expert Rev Hematol; 2011 Aug; 4(4):415-25. PubMed ID: 21801133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
    van Vliet C; Spagnolo DV
    Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell and NK cell lymphoproliferative disorders.
    Greer JP; Kinney MC; Loughran TP
    Hematology Am Soc Hematol Educ Program; 2001; ():259-81. PubMed ID: 11722988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms].
    Liang Q; Ye ZY; Su ZL; Lin HL; Shao CK; Lin SX; Rao HL; Mei KY; Zhao T; Liu YH; Luo DL; Zhu MG; Chen SH; Lin TY
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):291-5. PubMed ID: 20654150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.